Platelet transfusion thresholds in premature neonates (PlaNeT-2 trial)

Area of Science:

• Neonatal Medicine
• Hematology
• Pediatric Critical Care

Background:

• Preterm infants (< 34 weeks gestation) are susceptible to thrombocytopenia.
• Platelet transfusions are commonly used to manage low platelet counts in neonates.
• Current transfusion guidelines vary, with different thresholds for intervention.

Purpose of the Study:

• To investigate whether a higher platelet count threshold for transfusion reduces major bleeding or death in preterm infants.
• To compare the outcomes of transfusing platelets at < 50 x 10^9/L versus < 25 x 10^9/L in this population.

Main Methods:

• A clinical trial comparing two platelet transfusion strategies in preterm infants.
• Infants were randomized to receive platelets at either a higher (< 50 x 10^9/L) or lower (< 25 x 10^9/L) threshold.
• Primary outcomes included major bleeding events and mortality.

Main Results:

• Preterm infants transfused at the higher platelet count threshold (< 50 x 10^9/L) exhibited an increased risk of mortality or major bleeding.
• The study did not find a protective effect of the higher transfusion threshold.
• The underlying mechanisms for the increased risk at the higher threshold remain undetermined.

Conclusions:

• A higher platelet count threshold for transfusion in preterm infants (< 34 weeks) is associated with increased risk of death or major bleeding.
• Current evidence suggests that the lower threshold (< 25 x 10^9/L) may be safer for this vulnerable population.
• Further research is needed to elucidate the reasons behind this unexpected outcome.